Voyager Therapeutics, Inc.VYGRNASDAQ
Loading
Year-over-year operating income growth rate
Percentile
P59
Within normal range
vs 2Y Ago
0x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 2.16% |
| Q3 2025 | 16.47% |
| Q2 2025 | -5.57% |
| Q1 2025 | 9.42% |
| Q4 2024 | -177.93% |
| Q3 2024 | 8.29% |
| Q2 2024 | 7.16% |
| Q1 2024 | -129.93% |
| Q4 2023 | 283.22% |
| Q3 2023 | -16.05% |
| Q2 2023 | -120.69% |
| Q1 2023 | 600.28% |
| Q4 2022 | -270.08% |
| Q3 2022 | 174.57% |
| Q2 2022 | 9.29% |
| Q1 2022 | -474.43% |
| Q4 2021 | 122.68% |
| Q3 2021 | 12.03% |
| Q2 2021 | -11.71% |
| Q1 2021 | -7.84% |
| Q4 2020 | -128.07% |
| Q3 2020 | 1041.18% |
| Q2 2020 | 63.24% |
| Q1 2020 | -77.46% |
| Q4 2019 | 22.68% |
| Q3 2019 | -293.79% |
| Q2 2019 | 131.37% |
| Q1 2019 | -26.48% |
| Q4 2018 | -9.52% |
| Q3 2018 | 17.70% |
| Q2 2018 | -21.81% |
| Q1 2018 | -70.82% |
| Q4 2017 | 47.13% |
| Q3 2017 | -25.30% |
| Q2 2017 | -6.37% |
| Q1 2017 | -26.59% |
| Q4 2016 | -33.47% |
| Q3 2016 | -7.83% |
| Q2 2016 | -28.81% |
| Q1 2016 | -0.36% |